Depreciation in USD of ReShape Lifesciences Inc. from 2019 to Q1 2025

Taxonomy & unit: us-gaap: USD
Description: The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary: ReShape Lifesciences Inc. quarterly/annual Depreciation history and change rate from 2019 to Q1 2025.
ReShape Lifesciences Inc. Depreciation for the quarter ending March 31, 2025 was $4K, a 33.3% decline year-over-year.
ReShape Lifesciences Inc. annual Depreciation for 2024 was $22K, a 81.8% decline from 2023.
ReShape Lifesciences Inc. annual Depreciation for 2023 was $121K, a 63.3% decline from 2022.
ReShape Lifesciences Inc. annual Depreciation for 2022 was $330K, a 42.2% increase from 2021.

Depreciation, Quarterly (USD)

Depreciation, YoY Quarterly Change (%)

Depreciation, Annual (USD)

Depreciation, YoY Annual Change (%)

ReShape Lifesciences Inc. Quarterly Depreciation (USD)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q1 2025	$4K	-$2K	-33.3%	Jan 1, 2025	Mar 31, 2025	10-Q	2025-05-20
Q1 2024	$6K	-$31K	-83.8%	Jan 1, 2024	Mar 31, 2024	10-Q	2025-05-20
Q1 2023	$37K	-$57K	-60.6%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-15
Q1 2022	$94K	+$87K	+1243%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-15
Q1 2021	$7K	-$93K	-93%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-23
Q1 2020	$100K			Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-12

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
2024	$22K	-$99K	-81.8%	Jan 1, 2024	Dec 31, 2024	10-K	2025-04-04
2023	$121K	-$209K	-63.3%	Jan 1, 2023	Dec 31, 2023	10-K	2025-04-04
2022	$330K	+$98K	+42.2%	Jan 1, 2022	Dec 31, 2022	10-K	2024-04-01
2021	$232K	+$217K	+1447%	Jan 1, 2021	Dec 31, 2021	10-K	2023-04-17
2020	$15K	-$385K	-96.3%	Jan 1, 2020	Dec 31, 2020	10-K	2022-04-08
2019	$400K			Jan 1, 2019	Dec 31, 2019	10-K	2021-03-12

* An asterisk sign (*) next to the value indicates that the value is likely invalid.